A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)

Summary

This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in adults with GAD. Patients 18-65 years of age, with the diagnosis of GAD according to DSM-IV criteria, who fulfill the inclusion/exclusion criteria, will be enrolled in this study.

Timeline

Start

2005-08

Primary completion

—

Completion

2006-06

Drugs

Indications